Ruan Liqin, Fang Ningbo, Chen Weili, Wu Xiaoyong, Zhao Xin Hua, Wang Lu
Department of hepatobiliary surgery Jiujiang City Key Laboratory of Cell Therapy, Jiujiang NO.1 People's Hospital, Jiujiang, 332000, Jiangxi, China.
Oncology Department Jiujiang City Key Laboratory of Cell Therapy, Jiujiang NO.1 People's Hospital, Jiujiang, 332000, Jiangxi, China.
Respir Med Case Rep. 2024 Aug 29;51:102101. doi: 10.1016/j.rmcr.2024.102101. eCollection 2024.
The pancreas is a rare metastatic site for lung cancer. We report the case of a 66-year-old male with pulmonary sarcomatoid carcinoma (PSC) with pancreatic and right posterior renal fascia metastases treated with immunotherapy and platinum-based chemotherapy. A pathological biopsy of the right posterior fascial mass showed lung invasive adenocarcinoma and sarcomatoid carcinoma metastasis. Immunohistochemistry staining showed that PD- L1 expression was high and next-generation sequencing revealed KRAS and TP53 mutations. Camrelizumab and chemotherapy were administered, and the metastasis disappeared. Immunotherapy combined with platinum-based chemotherapy is effective in treating PSC with pancreatic metastases.
胰腺是肺癌罕见的转移部位。我们报告了一例66岁男性肺肉瘤样癌(PSC)伴胰腺及右肾后筋膜转移,接受免疫治疗和铂类化疗的病例。右后筋膜肿块的病理活检显示为肺浸润性腺癌和肉瘤样癌转移。免疫组化染色显示PD-L1表达高,二代测序显示KRAS和TP53突变。给予卡瑞利珠单抗和化疗后,转移灶消失。免疫治疗联合铂类化疗对治疗伴胰腺转移的PSC有效。